carvedilol has been researched along with beta-naphthoflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Honda, M; Ishida, K; Shimizu, T; Taguchi, M | 1 |
| Akao, T; Hashimoto, Y; Ishida, K; Taguchi, M | 1 |
2 other study(ies) available for carvedilol and beta-naphthoflavone
| Article | Year |
|---|---|
Stereoselective metabolism of carvedilol by the beta-naphthoflavone-inducible enzyme in human intestinal epithelial Caco-2 cells.
Topics: Adrenergic beta-Antagonists; beta-Naphthoflavone; Biotransformation; Caco-2 Cells; Calcitriol; Carbazoles; Carvedilol; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Flavanones; Glucuronosyltransferase; Humans; Isoenzymes; Propanolamines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stereoisomerism | 2007 |
Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cells.
Topics: Adrenergic beta-Antagonists; beta-Naphthoflavone; Caco-2 Cells; Carbazoles; Carvedilol; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Glucuronides; Humans; Microsomes; Oxidation-Reduction; Propanolamines; RNA, Messenger; Stereoisomerism; Theophylline | 2009 |